An Unexpected Finding of Hepatosplenomegaly in a Pediatric Patient. (January 2022)

• Record Type: Journal Article
• Authors: Barootes, Hailey C.; Prasad, Chitra; Rupar, C. Anthony; Ashok, Dhandapani
• Is Part Of: Clinical pediatrics. Volume 61:Number 1(2022)
• Page Start: 81
• Page End: 85
• Publication Date: 2022-01
• Subjects: Gaucher disease -- lysosomal storage disease -- hepatosplenomegaly -- imiglucerase replacement therapy; Pediatrics -- Periodicals; 618.920005
• DOI: 10.1177/00099228211059668
• Languages: English
• ISSNs: 0009-9228

Abstract

Gaucher disease (GD) is a rare autosomal recessive metabolic disorder. It is characterized by a deficiency of lysosomal glucocerebrosidase, which results in the accumulation of glycosphingolipid substrates, primarily glucosylceramide, in the phagocyte system. In GD Type 1, the liver, spleen, and bone marrow are typically affected. We report the case of a 7-year-old female with GD Type 1 who presented with hepatosplenomegaly detected incidentally following a motor vehicle accident. She was found to have concomitant thrombocytopenia and Erlenmeyer flask deformities of her lower limbs. Diagnosis was made on the basis of very low leukocyte β-glucocerebrosidase activity and elevated plasma chitotriosidase. DNA mutation studies revealed both c.1226A>G and c.116_1505 deletion (exons 3-11). The patient is currently managed with biweekly intravenous imiglucerase (Cerezyme) replacement therapy. She demonstrated resolution of thrombocytopenia and hepatosplenomegaly at 2-year follow-up. Physicians must consider this rare diagnosis in children presenting with hepatosplenomegaly to prompt timely management.